BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
Coagulation
,
Inflammatory disorder
,
Leukocyte
,
Amniocentesis
,
Lipitor
,
rs2476601
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SEPN1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Coronary artery
Uterus
Adipose tissue subcutaneous
Lung
Breast tissue
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Viremia
Infection due to Staphylococcus aureus
Muscular dystrophy
Disease due to Enterovirus
Injury of heart
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
AR A014418
sporidesmin
benzo(b)fluoranthene
Viral Vaccines
Fibroblast Growth Factor 8
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR193B
TRIB3
SH2B3
HIST1H1B
H1F0
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for SEPN1
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Natural History of Patients With Mutations in SEPN1 (SELENON) or LAMA2
Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenop…
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Molecular and Genetic Studies of Congenital Myopathies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ